SAGE-324
SAGE-324|  | |
| 임상자료 | |
|---|---|
| 기타이름 | BIIB124 | 
| 법적지위 | |
| 법적지위 | 
 | 
| 식별자 | |
| 
 | |
| CAS 번호 | |
| 펍켐 CID | |
| 화학물질 및 물리적 데이터 | |
| 공식 | C24H38N4O3 | 
| 어금니 질량 | 430.593 g·mol−1 | 
BIIB124라고도 알려진 SAGE-324는 GAB로 작동하는 실험용 약물입니다.AA 수용체 양성 알로스테릭 변조기. 본질적인 떨림을 위해 바이오젠에서 개발했습니다.[1][2][3][4][5]
참고문헌
- ^ Cerne, Rok; Lippa, Arnold; Poe, Michael M.; Smith, Jodi L.; Jin, Xiaoming; Ping, Xingjie; Golani, Lalit K.; Cook, James M.; Witkin, Jeffrey M. (June 2022). "GABAkines – Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors". Pharmacology & Therapeutics. 234: 108035. doi:10.1016/j.pharmthera.2021.108035.
- ^ Witkin, Jeffrey M.; Lippa, Arnold; Smith, Jodi L.; Jin, Xiaoming; Ping, Xingjie; Biggerstaff, Andrew; Kivell, Bronwyn M.; Knutson, Daniel E.; Sharmin, Dishary; Pandey, Kamal P.; Mian, Md Yeunus; Cook, James M.; Cerne, Rok (February 2022). "The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders". Pharmacology Biochemistry and Behavior. 213: 173321. doi:10.1016/j.pbb.2021.173321.
- ^ Quagliato, Laiana A.; Carta, Mauro G.; Nardi, Antonio E. (September 2022). "Panic Disorder Seeks More Specific Drugs for Treatment: Might the Amygdala Be the Best Target?". Journal of Clinical Psychopharmacology. 42 (5): 427–428. doi:10.1097/JCP.0000000000001591.
- ^ Cerne, Rok; Lippa, Arnold; Poe, Michael M.; Smith, Jodi L.; Jin, Xiaoming; Ping, Xingjie; Golani, Lalit K.; Cook, James M.; Witkin, Jeffrey M. (June 2022). "GABAkines – Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors". Pharmacology & Therapeutics. 234: 108035. doi:10.1016/j.pharmthera.2021.108035.
- ^ Ondo, William (1 January 2022). "Chapter Eleven - Enhancing GABA inhibition is the next generation of medications for essential tremor". International Review of Neurobiology. Academic Press. pp. 317–334.
 
                    

